Business
ADVANCED ORTHOMOLECULAR RESEARCH ACQUIRES BELLUS HEALTH'S CANADIAN SUBSIDIARY OVOS NATURAL HEALTH
Jan. 4, 2011 (Canada NewsWire Group) -- AOR is granted exclusive distribution rights to VIV...
About this update from Bluenergies Ltd.
[{"type":"text","content":"\n\n\n\n Jan. 4, 2011 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\n\nAOR is granted exclusive distribution rights to VIVIMIND™ in Canada; \nBELLUS Health retains all rights to VIVIMIND™ in other jurisdictions worldwide\n\n\nLAVAL, QC and CALGARY, Jan. 4 /CNW Telbec/ - BELLUS Health Inc. (TSX:\n BLU) ("BELLUS Health") and Advanced Orthomolecular Research Inc.\n ("AOR") announced today that they have entered into a share purchase\n agreement ("Share Purchase Agreement") with respect to BELLUS Health's\n wholly-owned Canadian subsidiary OVOS Natural Health Inc., and into a\n Canadian license and supply agreement ("License and Supply Agreement")\n relating to BELLUS Health's VIVIMIND™, a patented natural health\n product that has been shown to support the specific area of the brain\n known as the hippocampus, a region responsible for memory and learning.\n\n\nPursuant to the Share Purchase Agreement, AOR is acquiring all issued\n and outstanding shares of BELLUS Health's wholly-owned Canadian\n subsidiary OVOS Natural Health Inc. for a total consideration of $1\n million, consisting of an upfront payment of $350 000 and of a payment\n of $650 000 contingent upon the successful completion of a\n pre-established milestone event expected to occur within 18 months of\n the closing of the transaction. Pursuant to the License and Supply\n Agreement, BELLUS Health is granting AOR exclusive distribution rights\n for VIVIMIN...